{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:52:38Z","timestamp":1791067958434,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11046-026-01111-3","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:06:34Z","timestamp":1791007594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidrug Resistance and Host Adaptation in Candida Auris: From Molecular Mechanisms to Emerging Therapeutic Frontiers"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6319-5867","authenticated-orcid":false,"given":"Fenglin","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"1","key":"1111_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10482-012-9804-1","volume":"103","author":"J Poomtien","year":"2013","unstructured":"Poomtien J, Jindamorakot S, Limtong S, Pinphanichakarn P, Thaniyavarn J. Two new anamorphic yeasts species, Cyberlindnera samutprakarnensis sp. nov. and Candida thasaenensis sp. nov., isolated from industrial wastes in Thailand. Antonie Van Leeuwenhoek J Microbiol Serol. 2013;103(1):229\u201338. https:\/\/doi.org\/10.1007\/s10482-012-9804-1.","journal-title":"Antonie Van Leeuwenhoek J Microbiol Serol"},{"key":"1111_CR2","doi-asserted-by":"publisher","unstructured":"la Garza PR, Cruz-de la Cruz C, Bejarano JIC, Romo AEL, Delgado JV, Ramos BA, et al. A multicentric outbreak of Candida auris in Mexico: 2020 to 2023. Am J Infect Control 2024; 52(12): 1384\u20131389. https:\/\/doi.org\/10.1016\/j.ajic.2024.07.012.","DOI":"10.1016\/j.ajic.2024.07.012"},{"issue":"4","key":"1111_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jiph.2019.03.009","volume":"12","author":"W Alfouzan","year":"2019","unstructured":"Alfouzan W, Dhar R, Albarrag A, Al-Abdely H. The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Health. 2019;12(4):451\u20139. https:\/\/doi.org\/10.1016\/j.jiph.2019.03.009.","journal-title":"J Infect Public Health"},{"issue":"1","key":"1111_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajic.2023.08.018","volume":"52","author":"C Koutras","year":"2024","unstructured":"Koutras C, Wade RL. Ultraviolet-C mediated inactivation of Candida auris, a rapid emerging health threat. Am J Infect Control. 2024;52(1):133\u20135. https:\/\/doi.org\/10.1016\/j.ajic.2023.08.018.","journal-title":"Am J Infect Control"},{"issue":"5","key":"1111_CR5","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/s1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280\u201393. https:\/\/doi.org\/10.1016\/s1473-3099(24)00749-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1111_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.55730\/1300-0144.6059","volume":"55","author":"C A\u011falar","year":"2025","unstructured":"A\u011falar C, Erdem H, \u00c7a\u011f Y, Arda B, Balik R, Ba\u015ftu\u011f A, et al. Consensus paper on Candida auris by T\u00fcrkiye EKMUD, THSK of Ministry of Health of the Republic of T\u00fcrkiye, KLIMUD, TMC, TARD, TYBD and ID-IRI. Turkish J Med Sci. 2025;55(4):1039\u201362.","journal-title":"Turkish J Med Sci"},{"issue":"4","key":"1111_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.25259\/JLP_11_2024","volume":"16","author":"P Chheda","year":"2024","unstructured":"Chheda P, Shivaprakash S, Gupta N, Dama T, Biyani N, Bansode S. Genetic analysis of drug resistance mechanisms and phylogenetic clustering in Candida auris isolates from Western India. J Lab Physicians. 2024;16(4):447\u201353.","journal-title":"J Lab Physicians"},{"issue":"9","key":"1111_CR8","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/s2666-5247(24)00101-0","volume":"5","author":"C Suphavilai","year":"2024","unstructured":"Suphavilai C, Ko KKK, Lim KM, Tan MG, Boonsimma P, Chu JJK, et al. Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe. 2024;5(9):100878. https:\/\/doi.org\/10.1016\/s2666-5247(24)00101-0.","journal-title":"Lancet Microbe"},{"issue":"7","key":"1111_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cmi.2025.04.003","volume":"31","author":"KJ da Silva","year":"2025","unstructured":"da Silva KJ, Lucini F, dos Santos RA, Santos DA, Meis JF, Melhem MD, et al. How does antifungal resistance vary in Candida (Candidozyma) auris and its clades? Quantitative and qualitative analyses and their clinical implications. Clin Microbiol Infect. 2025;31(7):1146\u201356. https:\/\/doi.org\/10.1016\/j.cmi.2025.04.003.","journal-title":"Clin Microbiol Infect"},{"key":"1111_CR10","doi-asserted-by":"publisher","unstructured":"Kim HYP, Nguyen TAM, Kidd SP, Chambers JM, Alastruey-Izquierdo AP, Shin JM, et al. Candida auris-a systematic review to inform the world health organization fungal priority pathogens list. Med Mycol 2024; 62(6): https:\/\/doi.org\/10.1093\/mmy\/myae042.","DOI":"10.1093\/mmy\/myae042"},{"issue":"2","key":"1111_CR11","doi-asserted-by":"publisher","first-page":"e01223-01217","DOI":"10.1128\/jcm.01223-17","volume":"56","author":"L Leach","year":"2018","unstructured":"Leach L, Zhu Y, Chaturvedi S. Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples. J Clin Microbiol. 2018;56(2):e01223-01217. https:\/\/doi.org\/10.1128\/jcm.01223-17.","journal-title":"J Clin Microbiol"},{"key":"1111_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fmicb.2018.01119","volume":"9","author":"A Arastehfar","year":"2018","unstructured":"Arastehfar A, Fang W, Badali H, Vaezi A, Jiang W, Liao W, et al. Low-cost tetraplex PCR for the global spreading multi-drug resistant fungus, Candida auris and its phylogenetic relatives. Front Microbiol. 2018;9:1119. https:\/\/doi.org\/10.3389\/fmicb.2018.01119.","journal-title":"Front Microbiol"},{"issue":"9","key":"1111_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/jcm.00591-18","volume":"56","author":"M Yamamoto","year":"2018","unstructured":"Yamamoto M, Alshahni MM, Tamura T, Satoh K, Iguchi S, Kikuchi K, et al. Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP). J Clin Microbiol. 2018;56(9):10\u2013128. https:\/\/doi.org\/10.1128\/jcm.00591-18.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1111_CR14","doi-asserted-by":"publisher","first-page":"e01124-01120","DOI":"10.1128\/aac.01124-20","volume":"64","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Kilburn S, Kapoor M, Chaturvedi S, Shaw KJ, Chaturvedi V. In vitro activity of manogepix against multidrug-resistant and panresistant Candida auris from the New York outbreak. Antimicrob Agents Chemother. 2020;64(11):e01124-01120. https:\/\/doi.org\/10.1128\/aac.01124-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1111_CR15","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmi.2014.11.009","volume":"21","author":"AK Ghosh","year":"2015","unstructured":"Ghosh AK, Paul S, Sood P, Rudramurthy SM, Rajbanshi A, Jillwin TJ, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections. Clin Microbiol Infect. 2015;21(4):372\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.009.","journal-title":"Clin Microbiol Infect"},{"key":"1111_CR16","doi-asserted-by":"publisher","first-page":"104063","DOI":"10.1016\/j.meegid.2019.104063","volume":"76","author":"S Angeletti","year":"2019","unstructured":"Angeletti S, Ciccozzi M. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiology: an updating review. Infect Genet Evol. 2019;76:104063. https:\/\/doi.org\/10.1016\/j.meegid.2019.104063.","journal-title":"Infect Genet Evol"},{"issue":"5","key":"1111_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1089\/mdr.2018.0408","volume":"25","author":"MH Woodworth","year":"2019","unstructured":"Woodworth MH, Dynerman D, Crawford ED, Doernberg SB, Ramirez-Avila L, Serpa PH, et al. Sentinel case of Candida auris in the Western United States following prolonged occult colonization in a returned traveler from India. Microb Drug Resist. 2019;25(5):677\u201380. https:\/\/doi.org\/10.1089\/mdr.2018.0408.","journal-title":"Microb Drug Resist"},{"issue":"11","key":"1111_CR18","doi-asserted-by":"publisher","first-page":"e0072525","DOI":"10.1128\/aac.00725-25","volume":"69","author":"ML Alvarado Casas","year":"2025","unstructured":"Alvarado Casas ML, Triana D\u00edaz JA, Montilla-Escudero E, Prada Cardozo DA, Escand\u00f3n Hern\u00e1ndez P. Genomic epidemiology of Colombian resistant Candida auris isolates. Antimicrob Agents Chemother. 2025;69(11):e0072525. https:\/\/doi.org\/10.1128\/aac.00725-25.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1111_CR19","doi-asserted-by":"publisher","first-page":"01624","DOI":"10.1128\/aac.01624-21","volume":"66","author":"B Williamson","year":"2022","unstructured":"Williamson B, Wilk A, Guerrero KD, Mikulski TD, Elias TN, Sawh I, et al. Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility. Antimicrob Agents Chemother. 2022;66(1):01624\u2013721. https:\/\/doi.org\/10.1128\/aac.01624-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"1111_CR20","doi-asserted-by":"publisher","first-page":"19816","DOI":"10.1021\/acsomega.3c08134","volume":"9","author":"H Izumi","year":"2024","unstructured":"Izumi H, Nafie LA, Dukor RK. Effect of conformational variability on the drug resistance of Candida auris ERG11p and FKS1. ACS Omega. 2024;9(18):19816\u201323. https:\/\/doi.org\/10.1021\/acsomega.3c08134.","journal-title":"ACS Omega"},{"key":"1111_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jof10060392","author":"A Casimiro-Ramos","year":"2024","unstructured":"Casimiro-Ramos A, Bautista-Crescencio C, Vidal-Montiel A, Gonz\u00e1lez GM, Hern\u00e1ndez-Garc\u00eda JA, Hern\u00e1ndez-Rodr\u00edguez C, et al. Comparative genomics of the first resistant Candida auris strain isolated in Mexico: phylogenomic and pan-genomic analysis and mutations associated with antifungal resistance. J Fungi. 2024. https:\/\/doi.org\/10.3390\/jof10060392.","journal-title":"J Fungi"},{"issue":"10","key":"1111_CR22","doi-asserted-by":"publisher","first-page":"e00300-25","DOI":"10.1128\/aac.00300-25","volume":"69","author":"KS Barker","year":"2025","unstructured":"Barker KS, Santana DJ, Zhang Q, Peters TL, Rybak JM, Morschh\u00e4user J, et al. Mutations in TAC1B drive increased CDR1 and MDR1 expression and azole resistance in Candida auris. Antimicrob Agents Chemother. 2025;69(10):e00300-25. https:\/\/doi.org\/10.1128\/aac.00300-25.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1111_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/jof7020140","volume":"7","author":"V Di Pilato","year":"2021","unstructured":"Di Pilato V, Codda G, Ball L, Giacobbe DR, Willison E, Mikulska M, et al. Molecular epidemiological investigation of a nosocomial cluster of C. auris: evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J Fungi. 2021;7(2):140. https:\/\/doi.org\/10.3390\/jof7020140.","journal-title":"J Fungi"},{"issue":"4","key":"1111_CR24","doi-asserted-by":"publisher","first-page":"e0176722","DOI":"10.1128\/jcm.01767-22","volume":"61","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Hager KM, Manjari SR, Banavali NK, Chaturvedi V, Chaturvedi S. Development and validation of TaqMan chemistry probe-based rapid assay for the detection of echinocandin-resistance in Candida auris. J Clin Microbiol. 2023;61(4):e0176722. https:\/\/doi.org\/10.1128\/jcm.01767-22.","journal-title":"J Clin Microbiol"},{"issue":"7955","key":"1111_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41586-023-05856-5","volume":"616","author":"X Hu","year":"2023","unstructured":"Hu X, Yang P, Chai C, Liu J, Sun H, Wu Y, et al. Structural and mechanistic insights into fungal \u03b2-1, 3-glucan synthase FKS1. Nature. 2023;616(7955):190\u20138.","journal-title":"Nature"},{"key":"1111_CR26","doi-asserted-by":"publisher","first-page":"128322","DOI":"10.1016\/j.micres.2025.128322","volume":"301","author":"ZK Ross","year":"2025","unstructured":"Ross ZK, Alsayegh S, Zhao Y, McPherson S, Munro CA, Lorenz A. In vitro evolution of caspofungin resistance in Candidozyma auris via FKS1 hotspot I mutations results in moderate fitness trade-offs but no reduction in virulence. Microbiol Res. 2025;301:128322. https:\/\/doi.org\/10.1016\/j.micres.2025.128322.","journal-title":"Microbiol Res"},{"issue":"3","key":"1111_CR27","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1093\/infdis\/jiaf285","volume":"232","author":"LA Doorley","year":"2025","unstructured":"Doorley LA, Meza-Perez V, Jones SJ, Rybak JM. A Candidozyma (Candida) auris\u2013optimized episomal plasmid\u2013induced Cas9-editing system reveals the direct impact of the S639F-encoding FKS1 mutation. J Infect Dis. 2025;232(3):e529\u201336. https:\/\/doi.org\/10.1093\/infdis\/jiaf285.","journal-title":"J Infect Dis"},{"issue":"8","key":"1111_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/jof9080859","volume":"9","author":"LN Silva","year":"2023","unstructured":"Silva LN, Ramos LS, Oliveira SS, Magalh\u00e3es LB, Cypriano J, Abreu F, et al. Development of Echinocandin Resistance in Candida haemulonii: An Emergent, Widespread, and Opportunistic Fungal Pathogen. J Fungi. 2023;9(8):859. https:\/\/doi.org\/10.3390\/jof9080859.","journal-title":"J Fungi"},{"issue":"1","key":"1111_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12879-024-10435-8","volume":"25","author":"DS ElFeky","year":"2025","unstructured":"ElFeky DS, El-Wakil DM, Mwafy MM, Atia MM, Gohar NM. Comparative evaluation of antifungal susceptibility testing methods of invasive Candida species and detection of FKS genes mutations in caspofungin intermediate and resistant isolates. BMC Infect Dis. 2025;25(1):114. https:\/\/doi.org\/10.1186\/s12879-024-10435-8.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1111_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrmicro2875","volume":"10","author":"MD Leach","year":"2012","unstructured":"Leach MD, Klipp E, Cowen LE, Brown AJ. Fungal Hsp90: a biological transistor that tunes cellular outputs to thermal inputs. Nat Rev Microbiol. 2012;10(10):693\u2013704. https:\/\/doi.org\/10.1038\/nrmicro2875.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"1111_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/fmb.11.19","volume":"6","author":"DS Perlin","year":"2011","unstructured":"Perlin DS. Current perspectives on echinocandin class drugs. Future Microbiol. 2011;6(4):441\u201357. https:\/\/doi.org\/10.2217\/fmb.11.19.","journal-title":"Future Microbiol"},{"issue":"1","key":"1111_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmi.2025.07.002","volume":"32","author":"MC Arendrup","year":"2026","unstructured":"Arendrup MC, Guinea J, Arikan-Akdagli S, Meijer EF, Meis JF, Buil JB, et al. How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoints. Clin Microbiol Infect. 2026;32(1):56\u201361.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1111_CR33","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmi.2021.11.024","volume":"28","author":"JM Rybak","year":"2022","unstructured":"Rybak JM, Barker KS, Mu\u00f1oz JF, Parker JE, Ahmad S, Mokaddas E, et al. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clin Microbiol Infect. 2022;28(6):838\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.024.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"1111_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/mmi.15379","volume":"124","author":"A Chauhan","year":"2025","unstructured":"Chauhan A, Carolus H, Sofras D, Kumar M, Kumar P, Nair R, et al. Multi-omics analysis of experimentally evolved Candida auris isolates reveals modulation of sterols, sphingolipids, and oxidative stress in acquired amphotericin B resistance. Mol Microbiol. 2025;124(2):154\u201372. https:\/\/doi.org\/10.1111\/mmi.15379.","journal-title":"Mol Microbiol"},{"issue":"6","key":"1111_CR35","doi-asserted-by":"publisher","first-page":"e02276-21","DOI":"10.1128\/aac.02276-21","volume":"66","author":"R Shivarathri","year":"2022","unstructured":"Shivarathri R, Jenull S, Chauhan M, Singh A, Mazumdar R, Chowdhary A, et al. Comparative transcriptomics reveal possible mechanisms of amphotericin B resistance in Candida auris. Antimicrob Agents Chemother. 2022;66(6):e02276-21. https:\/\/doi.org\/10.1128\/aac.02276-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1111_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/spectrum.00892-23","volume":"11","author":"B Biswas","year":"2023","unstructured":"Biswas B, Rana A, Gupta N, Gupta I, Puria R, Thakur A. A novel robust method mimicking human substratum to dissect the heterogeneity of Candida auris biofilm formation. Microbiol Spectr. 2023;11(4):14. https:\/\/doi.org\/10.1128\/spectrum.00892-23.","journal-title":"Microbiol Spectr"},{"issue":"12","key":"1111_CR37","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1007\/s11255-025-04600-4","volume":"57","author":"V Zoi","year":"2025","unstructured":"Zoi V, Skoulatou M, Vassilikopoulos T, Vovlianou S. Managing Candida auris in dialysis units: challenges, strategies, and future directions. Int Urol Nephrol. 2025;57(12):4141\u201353.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1111_CR38","doi-asserted-by":"publisher","first-page":"e00680-00618","DOI":"10.1128\/mSphereDirect.00680-18","volume":"4","author":"EG Dominguez","year":"2019","unstructured":"Dominguez EG, Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, et al. Conserved role for biofilm matrix polysaccharides in Candida auris drug resistance. mSphere. 2019;4(1):e00680-00618. https:\/\/doi.org\/10.1128\/mSphereDirect.00680-18.","journal-title":"mSphere"},{"issue":"1","key":"1111_CR39","doi-asserted-by":"publisher","first-page":"9212","DOI":"10.1038\/s41467-024-53588-5","volume":"15","author":"TW Wang","year":"2024","unstructured":"Wang TW, Sofras D, Montelongo-Jauregui D, Paiva TO, Carolus H, Dufr\u00eane YF, et al. Functional redundancy in Candida auris cell surface adhesins crucial for cell-cell interaction and aggregation. Nat Commun. 2024;15(1):9212.","journal-title":"Nat Commun"},{"issue":"10","key":"1111_CR40","doi-asserted-by":"publisher","first-page":"e0044625","DOI":"10.1128\/msphere.00446-25","volume":"10","author":"M Abe","year":"2025","unstructured":"Abe M, Sadamoto S, Nagamori A, Shinozaki M, Oiki S, Otani A, et al. Candida auris persists in the vaginal microaerobic niche in the absence of interleukin-17A. mSphere. 2025;10(10):e0044625. https:\/\/doi.org\/10.1128\/msphere.00446-25.","journal-title":"mSphere"},{"issue":"6","key":"1111_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmi.2024.03.006","volume":"31","author":"L Kriegl","year":"2025","unstructured":"Kriegl L, Egger M, Boyer J, Hoenigl M, Krause R. New treatment options for critically important WHO fungal priority pathogens. Clin Microbiol Infect. 2025;31(6):922\u201330. https:\/\/doi.org\/10.1016\/j.cmi.2024.03.006.","journal-title":"Clin Microbiol Infect"},{"issue":"10370","key":"1111_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0140-6736(22)02324-8","volume":"401","author":"GR Thompson 3rd","year":"2023","unstructured":"Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, et al. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet. 2023;401(10370):49\u201359. https:\/\/doi.org\/10.1016\/s0140-6736(22)02324-8.","journal-title":"Lancet"},{"key":"1111_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02438-19","author":"M Helleberg","year":"2020","unstructured":"Helleberg M, J\u00f8rgensen KM, Hare RK, Datcu R, Chowdhary A, Arendrup MC. Rezafungin in vitro activity against contemporary Nordic clinical Candida isolates and Candida auris determined by the EUCAST reference method. Antimicrob Agents Chemother. 2020. https:\/\/doi.org\/10.1128\/aac.02438-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"1111_CR44","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1093\/ajhp\/zxac256","volume":"79","author":"AJ Sucher","year":"2022","unstructured":"Sucher AJ, Thai A, Tran C, Mantena N, Noronha A, Chahine EB. Ibrexafungerp: a new triterpenoid antifungal. Am J Health Syst Pharm. 2022;79(24):2208\u201321. https:\/\/doi.org\/10.1093\/ajhp\/zxac256.","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"1111_CR45","doi-asserted-by":"publisher","first-page":"e202314728","DOI":"10.1002\/anie.202314728","volume":"63","author":"M Jospe-Kaufman","year":"2024","unstructured":"Jospe-Kaufman M, Ben-Zeev E, Mottola A, Dukhovny A, Berman J, Carmeli S, et al. Reshaping echinocandin antifungal drugs to circumvent glucan synthase point-mutation-mediated resistance. Angew Chem Int Ed Engl. 2024;63(9):e202314728. https:\/\/doi.org\/10.1002\/anie.202314728.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1111_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jof10050362","author":"A Espinel-Ingroff","year":"2024","unstructured":"Espinel-Ingroff A, Wiederhold NP. A mini-review of in vitro data for Candida species, including C. auris, isolated during clinical trials of three new antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin. J Fungi. 2024. https:\/\/doi.org\/10.3390\/jof10050362.","journal-title":"J Fungi"},{"issue":"5","key":"1111_CR47","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1093\/cid\/ciaf185","volume":"81","author":"MR Hodges","year":"2025","unstructured":"Hodges MR, Tawadrous M, Cornely OA, Thompson GR, Slavin MA, Maertens JA, et al. Fosmanogepix for the treatment of invasive mold diseases caused by Aspergillus species and rare molds: a phase 2, open-label study (AEGIS). Clin Infect Dis. 2025;81(5):e302\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaf185.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1111_CR48","doi-asserted-by":"publisher","first-page":"e01419-22","DOI":"10.1128\/aac.01419-22","volume":"67","author":"JA Vazquez","year":"2023","unstructured":"Vazquez JA, Pappas PG, Boffard K, Paruk F, Bien PA, Tawadrous M, et al. Clinical efficacy and safety of a novel antifungal, Fosmanogepix, in patients with candidemia caused by Candida auris: results from a phase 2 trial. Antimicrob Agents Chemother. 2023;67(5):e01419-22. https:\/\/doi.org\/10.1128\/aac.01419-22.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1111_CR49","doi-asserted-by":"publisher","first-page":"e0171721","DOI":"10.1128\/spectrum.01717-21","volume":"10","author":"TG Maphanga","year":"2022","unstructured":"Maphanga TG, Mpembe RS, Naicker SD, Govender NP. In vitro antifungal activity of Manogepix and other antifungal agents against South African Candida auris isolates from bloodstream infections. Microbiol Spectr. 2022;10(1):e0171721. https:\/\/doi.org\/10.1128\/spectrum.01717-21.","journal-title":"Microbiol Spectr"},{"issue":"11","key":"1111_CR50","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/s1473-3099(25)00224-5","volume":"25","author":"JA Maertens","year":"2025","unstructured":"Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, et al. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Lancet Infect Dis. 2025;25(11):1177\u201388. https:\/\/doi.org\/10.1016\/s1473-3099(25)00224-5.","journal-title":"Lancet Infect Dis"},{"key":"1111_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.peptides.2019.02.002","volume":"113","author":"P Zhao","year":"2000","unstructured":"Zhao P, Xue Y, Li X, Li J, Zhao Z, Quan C, et al. Fungi-derived lipopeptide antibiotics developed since 2000. Peptides. 2000;113:52\u201365. https:\/\/doi.org\/10.1016\/j.peptides.2019.02.002.","journal-title":"Peptides"},{"key":"1111_CR52","doi-asserted-by":"publisher","unstructured":"Blin K, Shaw S, Vader L, Szenei J, Reitz Zachary L, Augustijn Hannah E, et al. antiSMASH 8.0: extended gene cluster detection capabilities and analyses of chemistry, enzymology, and regulation. Nucleic Acids Research 2025; 53(W1): W32-W38.https:\/\/doi.org\/10.1093\/nar\/gkaf334.","DOI":"10.1093\/nar\/gkaf334"},{"key":"1111_CR53","doi-asserted-by":"publisher","unstructured":"Dai T, Chen AX, Chow EWL, Pang LM, Li J, Verma CS, et al. A Cationic Supramolecule With Potent Antifungal Activity, Single-Species Selectivity, and Strong Synergy With Echinocandins. Adv Sci (Weinh) 2026; 13(41): e75480.https:\/\/https:\/\/doi.org\/10.1002\/advs.75480.","DOI":"10.1002\/advs.75480"},{"issue":"9","key":"1111_CR54","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/acsinfecdis.2c00193","volume":"8","author":"CM Wesseling","year":"2022","unstructured":"Wesseling CM, Martin NI. Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics. ACS Infect Dis. 2022;8(9):1731. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00193.","journal-title":"ACS Infect Dis"},{"issue":"5","key":"1111_CR55","doi-asserted-by":"publisher","first-page":"e0057024","DOI":"10.1128\/mbio.00570-24","volume":"15","author":"S Guha","year":"2024","unstructured":"Guha S, Cristy SA, Buda De Cesare G, Cruz MR, Lorenz MC, Garsin DA. Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis. MBio. 2024;15(5):e0057024. https:\/\/doi.org\/10.1128\/mbio.00570-24.","journal-title":"MBio"},{"issue":"1","key":"1111_CR56","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/s41467-022-33613-1","volume":"13","author":"MR Cruz","year":"2022","unstructured":"Cruz MR, Cristy S, Guha S, De Cesare GB, Evdokimova E, Sanchez H, et al. Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections. Nat Commun. 2022;13(1):6047. https:\/\/doi.org\/10.1038\/s41467-022-33613-1.","journal-title":"Nat Commun"},{"issue":"5","key":"1111_CR57","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s13346-024-01749-w","volume":"15","author":"B Fayed","year":"2025","unstructured":"Fayed B. Nanoparticles in the battle against Candida auris biofilms: current advances and future prospects. Drug Deliv Transl Res. 2025;15(5):1496\u2013512. https:\/\/doi.org\/10.1007\/s13346-024-01749-w.","journal-title":"Drug Deliv Transl Res"},{"issue":"19","key":"1111_CR58","doi-asserted-by":"publisher","first-page":"21183","DOI":"10.1021\/acsami.9b20708","volume":"12","author":"HH Lara","year":"2020","unstructured":"Lara HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J. Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles. ACS Appl Mater Interf. 2020;12(19):21183\u201391. https:\/\/doi.org\/10.1021\/acsami.9b20708.","journal-title":"ACS Appl Mater Interf"},{"key":"1111_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080461","author":"R Vazquez-Munoz","year":"2020","unstructured":"Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Bismuth nanoantibiotics display anticandidal activity and disrupt the biofilm and cell morphology of the emergent pathogenic yeast Candida auris. Antibiot (Basel). 2020. https:\/\/doi.org\/10.3390\/antibiotics9080461.","journal-title":"Antibiot (Basel)"},{"key":"1111_CR60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-micro-030117-020406","volume":"71","author":"JP Latg\u00e9","year":"2017","unstructured":"Latg\u00e9 JP, Beauvais A, Chamilos G. The cell wall of the human fungal pathogen Aspergillus fumigatus: biosynthesis, organization, immune response, and virulence. Annu Rev Microbiol. 2017;71:99\u2013116. https:\/\/doi.org\/10.1146\/annurev-micro-030117-020406.","journal-title":"Annu Rev Microbiol"},{"key":"1111_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-026-01485-x","author":"S Singh","year":"2026","unstructured":"Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, et al. \u03b2-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris. NPJ Vaccines. 2026. https:\/\/doi.org\/10.1038\/s41541-026-01485-x.","journal-title":"NPJ Vaccines"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01111-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01111-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01111-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:02:15Z","timestamp":1791064935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01111-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1111"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01111-3","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"85"}}